Table 1.
Roles of tissue-specific miRNAs in regulating lung cancer radiosensitivity
miRNA | Target | Effect | Response | Reference |
---|---|---|---|---|
miR208a | p21 | Decreases cell apoptosis | Radioresistant | 11 |
miR328-3p | γH2AX | Inhibits survival, predicts poor outcome of NSCLC patients | Radiosensitive | 14 |
miR30a | ATF1 | Inhibits DNA-damage repair, blocks G2/M arrest, and enhances radiation-induced apoptosis | Radiosensitive | 15 |
miR101 | ATM and DNA-PKcs | Inhibits DNA repair | Radiosensitive | 16 |
miR1323 | PRKDC | Enhances DNA-damage repair | Radioresistant | 17 |
miR34a | RAD51 | Regulates HR, inhibits DSB repair, miR34a delivery (MRX34) plus RT show therapeutic potential | Radiosensitive | 18 |
miR25 | BTG2 | Increases apoptosis | Radiosensitive | 22 |
miR29c | Bcl2 and Mcl1 | Increases apoptosis, longer relapse-free survival of patients | Radiosensitive | 24 |
miR122 | IGF1R | Enhances DSBs, apoptosis, and anchorage-independent growth inhibition induced by IR | Radiosensitive | 25 |
miR511 | TRIB2 | Inhibits cell growth, increased apoptosis and triggers Bax activation | Radiosensitive | 26 |
miR95 | SNX1 | Decreases apoptosis | Radioresistant | 27 |
miR124 | STAT3 | Enhances radiation-induced apoptosis | Radiosensitive | 28 |
miR‐198 | MET | Inhibits HGF–cMet signaling pathway, induces apoptosis | Radiosensitive | 29 |
miR21 | PDCD4 | Decreases cell apoptosis, activates PI3K–Akt–mTOR pathway, shorter median survival time | Radioresistant | 34,49 |
miR210 | — | Promotes hypoxic phenotype and DSB repair | Radioresistant | 35 |
miR148b | ROCK1 | Inhibits proliferation and EMT and promotes cell apoptosis | Radiosensitive | 38 |
miR200c | — | Activates EGFR-associated signaling, increases cell killing, and regulatesEMT | Radiosensitive | 39 |
miR145 | OCT4, SOX2, and Fascin 1 | suppressed the proliferation of CSCs and improved radioresistance | Radiosensitive | 41 |
miR21/95 | — | Inhibit PTEN, SNX1, and SGPP1 expression and elevates Akt phosphorylation | Radioresistant | 42 |
miR18a-5p | ATM and HIF1α | Inhibits DNA repair; predicts radiosensitivity | Radiosensitive | 43 |
miR373 | TIMP2 | Regulates PI3K–Akt and Smad signaling pathways | Radioresistant | 45 |
miR126 | — | Promotes apoptosis | Radiosensitive | 46 |
miR451 | — | Enhances apoptosis, activates PTEN | Radiosensitive | 47 |
miR99a | mTOR | Induces G1 arrest and apoptosis | Radiosensitive | 48 |
miR9 | NRP1 | Regulates PI3K–Akt, MARK/RK, and NFκB pathways, and inhibits apoptosis | Radioresistant | 50 |
miR9 and let-7 | — | Suppresses NFκB1 | Radiosensitive | 51 |
miR15a/16 | TLR1 | TLR1–NFκB pathway, increases apoptosis | Radiosensitive | 52 |
let-7a | — | Attenuates Kras expression | Radiosensitive | 53 |
miR155 | TP53INP1 | Enhances IR-induced senescence and cell killing, regulates p53 and p38 MAPK pathways | Radiosensitive | 54 |
miR214 | FoxO4 | Inhibits apoptosis and senescence and regulates p38 MAPK | Radioresistant | 55 |
Abbreviations: NSCLC, non-small-cell lung cancer; RT, radiotherapy; IR, ionizing radiation; PKcs, PK catalytic subunits; HR, homologous recombination; DSBs, double-strand breaks; EMT, epithelial–mesenchymal transition.